← Leaderboards
Prasad Manchem
Pleiogenix Inc.
$1,321,566
Attributed
$1,321,566
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,321,566 · 2
By mechanism
R44$1,025,643 · 1
R43$295,923 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Ethanol”
- Susie Dai · Texas A&M Agrilife Research$3,134,186
- Ana Cristina Llorente Izquierdo · University Of California, San Diego$2,249,410
- Carlos A. Blanco-Centurion · Medical University Of South Carolina$1,829,360
- Brian Crouch · Calla Health Foundation$1,822,439
- Xunjun Xiao · Washington University$1,759,094
- Monika Joshi · Pennsylvania State Univ Hershey Med Ctr$1,466,430
Research focus
EthanolFractureClinical Drug DevelopmentEffective TherapyFeedingFibrosisAcuteChronicDeath RateEdemaAffectAlcohol-Induced DisordersAlcoholsAffinityAgonistAnti-Inflammatory AgentsAdiponectinBiochemicalAlcohol ConsumptionCouplingAdrenal Cortex HormonesDesignAlcoholic HepatitisHealth Care Costs
Grant awards (2)
An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation$1,025,643
R44 · FY2025 · AA · contact PI
An innovative non-thiazolidinedione pan-PPAR agonist therapeutic for Alcoholic Hepatitis$295,923
R43 · FY2022 · AA · contact PI